The aim of this prospective observational study is to evaluate plasma HA, VCAM1, and PAI-1 as diagnostic biomarkers in patients with SOS following HSCT and to correlate serial measurements of these biomarkers with the evolution of SOS. The gene discussed is VCAM1; the disease is spondylo-ocular syndrome.